Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene for Negative and Cognitive Symptoms in Postmenopausal Schizophrenia
NCT03418831Phase 4Completed
- Sponsor
- Shanghai Mental Health Center
- Start
- Jul 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raloxifene in schizophrenia, sponsored by Shanghai Mental Health Center. Started Jul 2018; status: completed.
02
Drugs
raloxifene
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03418831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418831.